Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Abstract Proton pump inhibitors (PPI) are an invaluable therapy option for acid related diseases; however, PPI therapy is also linked to a series of side effects in cirrhosis, such as microbiome alterations, spontaneous bacterial peritonitis and hepatic encephalopathy. Decision tools to balance bene...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela Horvath, Florian Rainer, Mina Bashir, Bettina Leber, Bianca Schmerboeck, Ingeborg Klymiuk, Andrea Groselj-Strele, Marija Durdevic, Daniel E. Freedberg, Julian A. Abrams, Peter Fickert, Philipp Stiegler, Vanessa Stadlbauer
Format: article
Language:EN
Published: Nature Portfolio 2019
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/55e5d506aa1545a8ba05694f4b1cb4d1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/55e5d506aa1545a8ba05694f4b1cb4d1

Similar Items